| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | 0.0067 | 0.9 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.9 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.01 | 0.9 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.9 |
| mRNA | BMS-754807 | FIMM | pan-cancer | AAC | -0.022 | 0.9 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | 0.009 | 0.9 |
| mRNA | NSC-87877 | GDSC1000 | pan-cancer | AAC | -0.0069 | 0.9 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.9 |
| mRNA | MS-275 | FIMM | pan-cancer | AAC | 0.022 | 0.9 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | 0.01 | 0.9 |